Study Finds KSM-66 Ashwagandha Safe and Well Tolerated at 2,000-mg Daily Over 12 Weeks
A newly published clinical study found that 2,000 mg per day of KSM-66 Ashwagandha—more than three times the commonly studied 600 mg dose—was well tolerated, with no clinically significant changes observed in liver, kidney, or thyroid function markers.
Read More







